Tela Bio Inc. on Friday became the second Philadelphia-area life sciences company to go public this week, and the third to complete an initial public offering during the past three weeks.
The Malvern-based medical technology company sold 4 million shares of its common stock at $13 each for gross proceeds of $52 million. The amount of the offering could increase by another $7.8 million if underwriters exercise their full allotment of 600,000 additional shares to cover over allotments.
